U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. WILATE
  1. Approved Blood Products

WILATE

STN:  BL 125251
Proper Name: von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Tradename: WILATE
Manufacturer: OCTAPHARMA Pharmazeutika Produktionsges.m.b.H.

Indication:

  • In adults and adolescents with hemophilia A for routine prophylaxis to reduce the frequency of bleeding episodes and for on-demand treatment and control of bleeding episodes.
  • For the treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as patients with mild or moderate VWD in whom the use of desmopressin is known or suspected to be ineffective or contraindicated.
  • For routine prophylaxis to reduce the frequency of bleeding episodes in patients with von Willebrand Disease.

Product Information

Supporting Documents

 
Back to Top